{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:42:39Z","timestamp":1792690959055,"version":"4.5.0"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,10,6]]},"DOI":"10.1136\/thorax-2026-225819","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:20:33Z","timestamp":1792689633000},"page":"thorax-2026-225819","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory health in cystic fibrosis: much done, more to do!"],"prefix":"10.1136","author":[{"given":"Sharon E.","family":"Weinberg","sequence":"first","affiliation":[{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, England, UK"},{"name":"The University of Manchester Division of Infection Immunity and Respiratory Medicine, Manchester, Greater Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-4431","authenticated-orcid":false,"given":"Peter J","family":"Barry","sequence":"additional","affiliation":[{"name":"Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, England, UK"},{"name":"The University of Manchester Division of Infection Immunity and Respiratory Medicine, Manchester, Greater Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102210202136000_thorax-2026-225819v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2026102210202136000_thorax-2026-225819v1.2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026102210202136000_thorax-2026-225819v1.3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0261-2024","article-title":"Managing an ageing cystic fibrosis population: challenges and priorities","volume":"34","author":"Frost","year":"2025","journal-title":"Eur Respir Rev"},{"key":"2026102210202136000_thorax-2026-225819v1.4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2022.12.009","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on annual rate of lung function decline in people with cystic fibrosis","volume":"22","author":"Lee","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026102210202136000_thorax-2026-225819v1.5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/annalsats\/aaoag021","article-title":"Impact of 2 years of treatment with elexacaftor\/tezacaftor\/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial","volume":"23","author":"McNally","year":"2026","journal-title":"Ann Am Thorac Soc"},{"key":"2026102210202136000_thorax-2026-225819v1.6","doi-asserted-by":"crossref","unstructured":"Dhote T , Martin C , Fajac I , et al . Persistence of static lung hyperinflation in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor. Thorax 2026. doi:10.1136\/thorax-2026-225174","DOI":"10.1136\/thorax-2026-225174"},{"key":"2026102210202136000_thorax-2026-225819v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.09.005"},{"key":"2026102210202136000_thorax-2026-225819v1.8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","article-title":"Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials","volume":"13","author":"Keating","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026102210202136000_thorax-2026-225819v1.9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/crj.12763","article-title":"Static hyperinflation is associated with ventilatory limitation and exercise tolerance in adult cystic fibrosis","volume":"12","author":"Stevens","year":"2018","journal-title":"Clin Respir J"},{"key":"2026102210202136000_thorax-2026-225819v1.10","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-7-138","article-title":"Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis","volume":"7","author":"Kraemer","year":"2006","journal-title":"Respir Res"},{"key":"2026102210202136000_thorax-2026-225819v1.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-895OC"},{"key":"2026102210202136000_thorax-2026-225819v1.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-948OC"},{"key":"2026102210202136000_thorax-2026-225819v1.13","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21329"},{"key":"2026102210202136000_thorax-2026-225819v1.14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/resp.12885","article-title":"Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis","volume":"22","author":"Nicholson","year":"2017","journal-title":"Respirology"},{"key":"2026102210202136000_thorax-2026-225819v1.15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2025.11.016","article-title":"Elexacaftor\/tezacaftor\/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis","volume":"25","author":"Sagel","year":"2026","journal-title":"J Cyst Fibros"},{"key":"2026102210202136000_thorax-2026-225819v1.16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcf.2025.10.005","article-title":"Limited impact of Elexacaftor\/Tezacaftor\/Ivacaftor on CPET outcomes in an Italian cohort of people with Cystic Fibrosis: reinforcing the essential role of exercise training","volume":"25","author":"Retucci","year":"2026","journal-title":"J Cyst Fibros"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:20:35Z","timestamp":1792689635000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":16,"alternative-id":["10.1136\/thorax-2026-225819"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225819","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}